Moreover, genes involved in de novo lipogenesis, such as AKT2, SREBP1c, PPARγ, ACC, and FAS, are dramatically upregulated in HCV‐HCC compared to control liver, suggesting robust activation of de novo lipogenesis. The gene discussed is SREBF1; the disease is hepatocellular carcinoma.